Brilinta

Brilinta Description

Manufacturer:

AstraZeneca

Distributor:

Zuellig Pharma
Full Prescribing Info
Description
60 mg: Each film-coated tablet contains 60 mg ticagrelor.
90 mg: Each film-coated tablet contains 90 mg ticagrelor.
Brilinta contains less than 1 mmol sodium (23 mg) per dose, i.e. is essentially 'sodium-free'.
Excipients/Inactive Ingredients: 60 mg: Tablet core: Mannitol (E421), Dibasic calcium phosphate dihydrate, Magnesium stearate (E470b), Sodium starch glycolate type A, Hydroxypropylcellulose (E463).
Tablet coating: Titanium dioxide (E171), Ferric oxide black (E172), Ferric oxide red (E172), Polyethylene glycol 400, Hypromellose (E464).
90 mg: Core: Mannitol (E421), Dibasic calcium phosphate, Magnesium stearate (E470b), Sodium starch glycolate, Hydroxypropyl-cellulose (E463).
Coating: Talc, Titanium dioxide (E171), Ferric oxide yellow (E172), Polyethylene-glycol 400, Hypromellose (E464).
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in